n-formylmethionylphenylalanine has been researched along with Pulmonary Alveolar Proteinosis in 1 studies
Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, RM | 1 |
| Dauber, JH | 1 |
| Rogers, RM | 1 |
1 other study available for n-formylmethionylphenylalanine and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis.
Topics: Cell Migration Inhibition; Chemotactic Factors; Dipeptides; Endotoxins; Humans; Macrophages; Pulmona | 1989 |